A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel.
暂无分享,去创建一个
Mao Chen | Yuan-ning Xu | J. Wei | De-jia Huang | Xiao-jing Liu | Yuan‐ning Xu | Jiafu Wei | De‐jia Huang
[1] Deepak L. Bhatt,et al. Clopidogrel with or without omeprazole in coronary artery disease. , 2010, The New England journal of medicine.
[2] L. Køber,et al. Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use , 2010, Annals of Internal Medicine.
[3] K. Murray,et al. Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors , 2010, Annals of Internal Medicine.
[4] E. Antman,et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials , 2009, The Lancet.
[5] Keshav R. Nayak,et al. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. , 2009, The American journal of cardiology.
[6] Peter C. Austin,et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel , 2009, Canadian Medical Association Journal.
[7] M. Hadamitzky,et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel , 2009, Thrombosis and Haemostasis.
[8] P Michael Ho,et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. , 2009, JAMA.
[9] S. Steinhubl,et al. Abstract 3999: Baseline Proton Pump Inhibitor Use is Associated with Increased Cardiovascular Events With and Without the Use of Clopidogrel in the CREDO Trial , 2008 .
[10] R. Epstein,et al. Abstract 3998: Proton Pump Inhibitors Effect on Clopidogrel Effectiveness: The Clopidogrel Medco Outcomes Study , 2008 .
[11] Deepak L. Bhatt,et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2008, Circulation.
[12] Michael W Kattan,et al. Meta-analysis: Its strengths and limitations. , 2008, Cleveland Clinic journal of medicine.
[13] Dominique Mottier,et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. , 2008, Journal of the American College of Cardiology.
[14] Jeffrey L. Anderson,et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[15] E. Antman,et al. Prasugrel Compared With High Loading– and Maintenance–Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial , 2007, Circulation.
[16] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[17] A. Kastrati,et al. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. , 2004, European heart journal.
[18] S. Steinhubl,et al. Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial , 2003, Circulation.
[19] T. Heer,et al. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. , 2003, The American journal of cardiology.
[20] Paul B. Watkins,et al. Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction , 2003, Circulation.